FDA Center for Drug Evaluation & Research Issues Warning Letter to Pine Pharmaceuticals
October 06, 2026
October 06, 2026
WASHINGTON, Oct. 6 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Pine Pharmaceuticals LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Alfonse J. Muto PharmD, Owner, Pine Pharmaceuticals, LLC, 355 Riverwalk Parkway, Tonawanda, NY 14150-5837, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
* * *
Recipient: Alfonse J. Muto PharmD, Owner, Pine Pharmaceuticals, LLC, 355 Riverwalk Parkway, Tonawanda, NY 14150-5837, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
